J Clin Endocrinol Metab 88(4):17721779
Certificates of Analysis (COAs) are provided for available production lots
For people who meet clinical BMI criteria, have tried sustained diet and exercise without lasting results, and lack insurance coverage for FDA-approved GLP-1s, Yucca Health's compounded options may represent a financially accessible path to medications that clinical evidence suggests can support meaningful weight loss alongside lifestyle changes
By encasing glutathione in tiny lipid bubbles called liposomes, this advanced formula helps deliver the antioxidant through your gut and directly into your cells without being broken down along the way
Ideal candidates include individuals struggling with obesity, those with weight-related health conditions, and non-diabetics who have not achieved results through diet and exercise alone
In addition, knockdown of xCT exacerbates Ang II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice